JP2004502674A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502674A5
JP2004502674A5 JP2002507781A JP2002507781A JP2004502674A5 JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5 JP 2002507781 A JP2002507781 A JP 2002507781A JP 2002507781 A JP2002507781 A JP 2002507781A JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5
Authority
JP
Japan
Prior art keywords
methyl
isopropyl
pyridyl
pyrrole
dichlorophenylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502674A (ja
Filing date
Publication date
Priority claimed from GBGB0016453.3A external-priority patent/GB0016453D0/en
Application filed filed Critical
Publication of JP2004502674A publication Critical patent/JP2004502674A/ja
Publication of JP2004502674A5 publication Critical patent/JP2004502674A5/ja
Pending legal-status Critical Current

Links

JP2002507781A 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体 Pending JP2004502674A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016453.3A GB0016453D0 (en) 2000-07-04 2000-07-04 Pyrrole derivatives
PCT/EP2001/004832 WO2002002524A1 (en) 2000-07-04 2001-04-30 Pyrrole derivatives for treating aids

Publications (2)

Publication Number Publication Date
JP2004502674A JP2004502674A (ja) 2004-01-29
JP2004502674A5 true JP2004502674A5 (enExample) 2005-02-24

Family

ID=9895031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507781A Pending JP2004502674A (ja) 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体

Country Status (17)

Country Link
US (1) US6737429B2 (enExample)
EP (1) EP1301481A1 (enExample)
JP (1) JP2004502674A (enExample)
KR (1) KR100549884B1 (enExample)
CN (1) CN1440385A (enExample)
AR (1) AR028602A1 (enExample)
AU (2) AU2001263874B2 (enExample)
BR (1) BR0112241A (enExample)
CA (1) CA2412270A1 (enExample)
EC (1) ECSP014109A (enExample)
GB (1) GB0016453D0 (enExample)
GT (1) GT200100111A (enExample)
MX (1) MXPA02012409A (enExample)
PA (1) PA8516201A1 (enExample)
PE (1) PE20020269A1 (enExample)
UY (1) UY26720A1 (enExample)
WO (1) WO2002002524A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405849A1 (en) * 2002-10-04 2004-04-07 Corning Incorporated Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
US7569536B2 (en) * 2003-12-26 2009-08-04 Masatoshi Hagiwara Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
KR101178747B1 (ko) 2004-09-30 2012-09-03 다케다 야쿠힌 고교 가부시키가이샤 프로톤 펌프 저해제
TW200628446A (en) * 2004-12-14 2006-08-16 Takeda Pharmaceuticals Co Substituted pyrrole derivative
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
PE20070540A1 (es) 2005-08-30 2007-06-26 Takeda Pharmaceutical Derivados de pirrol como inhibidores de la secrecion acida
CA2665007A1 (en) * 2006-10-06 2008-05-08 Merck & Co., Inc. Non-nucleoside reverse transcriptase inhibitors
CN101677977A (zh) * 2006-11-10 2010-03-24 欣达克斯制药公司 用于治疗癌症的ERα+配体和组蛋白脱乙酰化酶抑制剂组合
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009015180A2 (en) * 2007-07-23 2009-01-29 Syndax Pharmaceuticals, Inc. Novel compounds and methods of using them
SG185313A1 (en) * 2007-10-16 2012-11-29 Nikon Corp Illumination optical system, exposure apparatus, and device manufacturing method
US20090131367A1 (en) * 2007-11-19 2009-05-21 The Regents Of The University Of Colorado Combinations of HDAC Inhibitors and Proteasome Inhibitors
UA105185C2 (uk) 2008-08-27 2014-04-25 Такеда Фармасьютікал Компані Лімітед Піроли
GB0823001D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Thiophene,furan and pyrrole derivatives with plant growth regulating properties
CN101775011B (zh) * 2009-01-13 2013-07-31 中国人民解放军军事医学科学院毒物药物研究所 N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用
US20230058961A1 (en) * 2019-11-19 2023-02-23 New York Blood Center, Inc. Substituted heterocyclics with therapeutic activity in hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4282242A (en) * 1980-03-07 1981-08-04 Pfizer Inc. Antidiabetic pyrrolecarboxylic acids
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
RU2130453C1 (ru) * 1992-12-17 1999-05-20 Пфайзер Инк. Замещенные пиразолы, фармацевтическая композиция на их основе, способ лечения, промежуточный продукт
FI964893A7 (fi) * 1994-06-06 1996-12-05 Pfizer Substituoituja pyratsoleja, jotka ovat aktiivisia kortikotropiinin vap auttamistekijän (CRF) antagonisteina
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
EP0912548A1 (en) * 1996-07-11 1999-05-06 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
DE19963174A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen

Similar Documents

Publication Publication Date Title
JP2004502674A5 (enExample)
JP2021535104A5 (enExample)
RU2425838C2 (ru) Ингибиторы iap
JP2008502700A5 (enExample)
RU2312105C9 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
RU2439068C2 (ru) Модуляторы mglur5
RU97107997A (ru) Соединения дигалогенпропена, содержащие их инсектицидно/акарицидные агенты, и интермедиаты для их получения
JP2019518036A5 (enExample)
JP2005527625A5 (enExample)
JP2013516415A5 (enExample)
JP2020516671A5 (enExample)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
JP2010540462A5 (enExample)
JP2021535134A5 (enExample)
JP2004517080A5 (enExample)
JP2010513304A5 (enExample)
JP2010529991A5 (enExample)
JP2007508346A5 (enExample)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2007308471A5 (enExample)
JP2004511469A5 (enExample)
JP2011500679A5 (enExample)
JP2020532589A5 (enExample)
RU2017145929A (ru) МОДУЛЯТОРЫ ROR ГАММА(RORγ)
JP2020500192A5 (enExample)